Dr. Razani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 Lothrop Street
BST10 E1043
Pittsburgh, PA 15261
Education & Training
- Washington University/B-JH/SLCH ConsortiumFellowship, Cardiovascular Disease, 2005 - 2009
- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2003 - 2005
- Albert Einstein College of MedicineClass of 2003
- Albert Einstein College of MedicinePh.D., Molecular Pharmacology, 2001
- Albert Einstein College of MedicineMS, Molecular Pharmacology, 1999
- University of California, BerkeleyBS, Electrical Engineering and Computer Science, 1992 - 1996
- University of California, BerkeleyBA, Molecular and Cellular Biology, 1992 - 1996
Certifications & Licensure
- MO State Medical License 2006 - 2025
Awards, Honors, & Recognition
- David L. Williams Lectureship and Award Kern Lipid Conference, 2015
- Irvine H. Page Young Investigator Research Award ATVB Scientific Sessions, 2014
- Roger Davis Investigator Award for Transitional Faculty Kern Lipid Conference, 2013
- Join now to see all
Publications & Presentations
PubMed
- 39 citationsKeap1/Cullin3 Modulates p62/SQSTM1 Activity via UBA Domain Ubiquitination.YouJin Lee, Tsui-Fen Chou, Sara K Pittman, Amy L Keith, Babak Razani
Cell Reports. 2017-04-04 - 1690 citationsGuidelines for the use and interpretation of assays for monitoring autophagy (4th edition)Daniel J. Klionsky, Amal Kamal Abdel-Aziz, Sara Abdelfatah, Mahmoud Abdellatif, Asghar Abdoli
Autophagy. 2021-02-08 - 167 citationsLong COVID, a comprehensive systematic scoping review.Hossein Akbarialiabad, Mohammad Hossein Taghrir, Ashkan Abdollahi, Nasrollah Ghahramani, Manasi Kumar
Infection. 2021-07-28
Journal Articles
- PPARγ Deficiency Suppresses the Release of IL-1β and IL-1α in Macrophages via a Type 1 IFN–Dependent MechanismKassandra J Weber, Joel D Schilling, Babak Razani, The Journal of Immunology
- Ursolic acid enhances macrophage autophagy and attenuates atherosclerosisLeng S, Iwanowycz S, Saaoud F, Wang J, Wang Y, Sergin I, Razani B, and Fan D., J Lipid Res, 1/1/2016
- Inclusion bodies enriched for p62 and polyubiquitinated proteins in macrophages protect against atherosclerosisSergin I, Bhattacharya S, Emanuel R, Esen E, Stokes CJ, Evans TD, Arif B, Curci JA, and Razani B., Sci Signal., 1/1/2016
- Join now to see all
Lectures
- Building a Better Macrophage to Treat Atherosclerosis and Associated Metabolic ConditionsGraz, Austria - 1/9/2016
- Building a Better Macrophage to Treat Metabolic DiseaseCedars-Sinai Medical Center, Los Angeles, CA - 1/8/2016
- Harnessing the Autophagy-Lysosomal Biogenesis Response in Macrophages to Treat AtherosclerosisVail, CO, 2015; Seoul, South Korea, 2015 - 1/12/2015
- Join now to see all
Press Mentions
- High-Protein Diet Isn't All Good News; New Study Reveals a Dangerous FlipsideSeptember 16th, 2024
- 46 Cardiology Leaders on the Move in 2022January 23rd, 2023
- How Can High Protein Powder Intake Cause a Heart Attack?May 2nd, 2021
- Join now to see all
Grant Support
- DE Novo Lipogenesis In Myocardial DysfunctionNational Heart, Lung, And Blood Institute2010–2011
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: